Non-alcoholic fatty liver disease associated with increased arterial stiffness in subjects with normal glucose tolerance, but not pre-diabetes and diabetes

Diabetes and Vascular Disease Research

Volumn 12, Issue 5, 2015, Pages 359-365

  Chou, Chieh Ying ^a   Yang, Yi Ching ^a,b   Wu, Jin Shang ^a,b   Sun, Zih Jie ^a   Lu, Feng Hwa ^a,b   Chang, Chih Jen ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

arterial stiffness; diabetes; Non alcoholic fatty liver disease; normal glucose tolerance; pre diabetes

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ANKLE BRACHIAL INDEX; ARTERIAL STIFFNESS; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; PULSE WAVE; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; AGED; BLOOD FLOW VELOCITY; COMPLICATION; DIABETES MELLITUS; GLUCOSE TOLERANCE TEST; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDIABETIC STATE; RISK FACTOR;

ADULT; AGED; ANKLE BRACHIAL INDEX; BLOOD FLOW VELOCITY; DIABETES MELLITUS; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PREDIABETIC STATE; RISK FACTORS; VASCULAR STIFFNESS;

EID: 84938701991     PISSN: 14791641     EISSN: 17528984     Source Type: Journal    
DOI: 10.1177/1479164115585009     Document Type: Article

References (37)

1. Angulo P, Lindor KD,. Non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2002; 17: S186-S190.
2. Anstee QM, Targher G, Day CP,. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol 2013; 10: 330-344.
3. Harrison SA, Kadakia S, Lang KA,. Non-alcoholic steatohepatitis: what we know in the new millennium. Am J Gastroenterol 2002; 97: 2714-2724.
4. Kawai T, Ohishi M, Onishi M,. Prognostic impact of regional arterial stiffness in hypertensive patients. Heart Vessels. Epub ahead of print 25 2014. DOI: 10.1007/s00380-00014-00485-00388.
5. Yamashina A, Tomiyama H, Arai T,. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res 2003; 26: 615-622.
6. Liu IT, Wu JS, Yang YC,. Mild chronic kidney disease associated with greater risk of arterial stiffness in elderly adults. J Am Geriatr Soc 2013; 61: 1758-1762.
7. Kim BJ, Kim NH, Kim BS,. The association between non-alcoholic fatty liver disease, metabolic syndrome and arterial stiffness in non-diabetic, non-hypertensive individuals. Cardiology 2012; 123: 54-61.
8. Yu KJ, Zhang MJ, Li Y,. Increased whole blood viscosity is associated with arterial stiffness in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2014; 29: 540-544.
9. Gkaliagkousi E, Douma S,. The pathogenesis of arterial stiffness and its prognostic value in essential hypertension and cardiovascular diseases. Hippokratia 2009; 13: 70-75.
10. Chen JY, Chou CH, Tsai WC,. Effects of increased systemic inflammation and central obesity on arterial stiffness in patients with non-alcoholic fatty liver disease. J Am Soc Hypertens 2012; 6: 253-260.
11. Catena C, Bernardi S, Sabato N,. Ambulatory arterial stiffness indices and non-alcoholic fatty liver disease in essential hypertension. Nutr Metab Cardiovasc Dis 2013; 23: 389-393.
12. Salvi P, Ruffini R, Agnoletti D,. Increased arterial stiffness in non-alcoholic fatty liver disease: the Cardio-GOOSE study. J Hypertens 2010; 28: 1699-1707.
13. Lee YJ, Shim JY, Moon BS,. The relationship between arterial stiffness and non-alcoholic fatty liver disease. Dig Dis Sci 2012; 57: 196-203.
14. Vlachopoulos C, Manesis E, Baou K,. Increased arterial stiffness and impaired endothelial function in non-alcoholic Fatty liver disease: a pilot study. Am J Hypertens 2010; 23: 1183-1189.
15. Huang RC, Beilin LJ, Ayonrinde O,. Importance of cardiometabolic risk factors in the association between non-alcoholic fatty liver disease and arterial stiffness in adolescents. Hepatology 2013; 58: 1306-1314.
16. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014; 37: S81-S90.
17. Son JI, Rhee SY, Woo JT,. Hemoglobin A1c may be an inadequate diagnostic tool for diabetes mellitus in anemic subjects. Diabetes Metab J 2013; 37: 343-348.
18. Aboyans V, Criqui MH, Abraham P,. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation 2012; 126: 2890-2909.
19. Saverymuttu SH, Joseph AE, Maxwell JD,. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J 1986; 292: 13-15.
20. Tchelepi H, Ralls PW, Radin R,. Sonography of diffuse liver disease. J Ultrasound Med 2002; 21: 1023-1032.
21. Angulo P, Hui JM, Marchesini G,. The NAFLD fibrosis score: a non-invasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 2007; 45: 846-854.
22. Riquelme A, Arrese M, Soza A,. Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics. Liver Int 2009; 29: 82-88.
23. Dogru T, Ercin CN, Erdem G,. Increased hepatic and circulating interleukin-6 levels in human non-alcoholic steatohepatitis. Am J Gastroenterol 2008; 103: 3217-3218.
24. Jarrar MH, Baranova A, Collantes R,. Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2008; 27: 412-421.
25. Yesilova Z, Yaman H, Oktenli C,. Systemic markers of lipid peroxidation and antioxidants in patients with non-alcoholic fatty liver disease. Am J Gastroenterol 2005; 100: 850-855.
26. Kim SG, Kim HY, Seo JA,. Relationship between serum adiponectin concentration, pulse wave velocity and non-alcoholic fatty liver disease. Eur J Endocrinol 2005; 152: 225-231.
27. Flechtner-Mors M, George SN, Oeztuerk S,. Association of adiponectin with hepatic steatosis: a study of 1,349 subjects in a random population sample. BMC Res Notes 2014; 7: 207.
28. Day CP,. From fat to inflammation. Gastroenterology 2006; 130: 207-210.
29. Mahmud A, Feely J,. Adiponectin and arterial stiffness. Am J Hypertens 2005; 18: 1543-1548.
30. Ha CY, Kim JY, Paik JK,. The association of specific metabolites of lipid metabolism with markers of oxidative stress, inflammation and arterial stiffness in men with newly diagnosed type 2 diabetes. Clin Endocrinol 2012; 76: 674-682.
31. Rajkovic N, Zamaklar M, Lalic K,. Relationship between obesity, adipocytokines and inflammatory markers in type 2 diabetes: relevance for cardiovascular risk prevention. Int J Environ Res Public Health 2014; 11: 4049-4065.
32. Wakabayashi I, Masuda H,. Association of acute-phase reactants with arterial stiffness in patients with type 2 diabetes mellitus. Clin Chim Acta 2006; 365: 230-235.
33. Paik JK, Kim M, Kwak JH,. Increased arterial stiffness in subjects with impaired fasting glucose. J Diabetes Complications 2013; 27: 224-228.
34. Lee HY, Oh BH,. Aging and arterial stiffness. Circ J 2010; 74: 2257-2262.
35. Satoh H, Saijo Y, Kishi R,. Brachial-ankle pulse wave velocity is an independent predictor of incident hypertension in Japanese normotensive male subjects. Environ Health Prev Med 2011; 16: 217-223.
36. Tanaka H, Munakata M, Kawano Y,. Comparison between carotid-femoral and brachial-ankle pulse wave velocity as measures of arterial stiffness. J Hypertens 2009; 27: 2022-2027.
37. Polyzos SA, Mantzoros CS,. Necessity for timely non-invasive diagnosis of non-alcoholic fatty liver disease. Metabolism 2014; 63: 161-167.